The Conjunctivitis Treatment Global Market Report 2024 by The Business Research Company provides market overview across 60+ geographies in the seven regions – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, encompassing 27 major global industries. The report presents a comprehensive analysis over a ten-year historic period (2010-2021) and extends its insights into a ten-year forecast period (2023-2033).
Learn More On The Conjunctivitis Treatment Market:
https://www.thebusinessresearchcompany.com/report/conjunctivitis-treatment-global-market-report
According to The Business Research Company’s Conjunctivitis Treatment Global Market Report 2024, The conjunctivitis treatment market size has grown steadily in recent years. It will grow from $4.49 billion in 2023 to $4.7 billion in 2024 at a compound annual growth rate (CAGR) of 4.6%. The growth in the historic period can be attributed to globalization of eye care services, increased affordability and accessibility, demand for combination therapies, innovation in anti-inflammatory treatments, growth in eye care infrastructure..
The conjunctivitis treatment market size is expected to see steady growth in the next few years. It will grow to $5.48 billion in 2028 at a compound annual growth rate (CAGR) of 4.0%. The growth in the forecast period can be attributed to focus on preventive healthcare, rise in global incidence of conjunctivitis, growth in healthcare awareness and access, increase in environmental allergens, expanding aging population.. Major trends in the forecast period include regulatory shifts in treatment approvals, focus on comfort and symptom management, integration of artificial intelligence in diagnosis, demand for combination therapies, growth in herbal and alternative remedies..
The rising prevalence of conjunctivitis cases is expected to propel the growth of the conjunctivitis treatment market going forward. Conjunctivitis refers to the inflammation of the conjunctiva, the thin, clear tissue that covers the white part of the eye and lines the inner surface of the eyelids. The growth of the conjunctivitis treatment market is driven by the increased demand for treatment options as more individuals seek medical attention and treatment due to the rising prevalence of conjunctivitis. For instance, in June 2022, according to the American Medical Association, a US-based professional association, the prevalence of viral conjunctivitis was found to be higher than bacterial conjunctivitis among adults, accounting for 78% compared to 16%, respectively, in the year 2022. Further, bacterial conjunctivitis was higher at 71% among children, while viral conjunctivitis accounted for 16%. Therefore, the rising prevalence of conjunctivitis cases drives the demand for the conjunctivitis treatment market.
Get A Free Sample Of The Report (Includes Graphs And Tables):
https://www.thebusinessresearchcompany.com/sample.aspx?id=12051&type=smp
The conjunctivitis treatment market covered in this report is segmented –
1) By Drug Class: Antibiotics, Antiviral, Anti-Allergic, Artificial Tears
2) By Disease Type: Allergic Conjunctivitis, Bacterial Conjunctivitis, Viral Conjunctivitis
3) By Route Of Administration: Oral, Topical
4) By End-Users: Hospitals, Homecare, Specialty Clinics, Other End-Users
Product innovation has emerged as a key trend gaining popularity in the conjunctivitis treatment market. Major companies operating in the conjunctivitis treatment market are concentrating on creating innovative products to strengthen their position in the market. For instance, in March 2022, Johnson & Johnson Vision Care, a US-based division of Johnson & Johnson focused specifically on eye health and vision care, received US FDA approval for ACUVUE Theravision with Ketotifen, the world’s first drug-eluting contact lens. This innovative technology combines ACUVUE daily disposable contact lenses with an established antihistamine, creating a new category in the market. ACUVUE Theravision with Ketotifen is indicated for preventing ocular itch caused by allergic conjunctivitis and providing vision correction for suitable contact lens wearers without red eyes and with up to 1.00 D of astigmatism.
The conjunctivitis treatment market report table of contents includes:
1. Executive Summary
2. Conjunctivitis Treatment Market Characteristics
3. Conjunctivitis Treatment Market Trends And Strategies
4. Conjunctivitis Treatment market analysis
5.Conjunctivitis Treatment Market Size And Growth
6.Conjunctivitis Treatment Segmentation
7. Conjunctivitis Treatment Regional And Country Analysis
.
.
.
27.Conjunctivitis Treatment Competitive Landscape And Company Profiles
28. Conjunctivitis Treatment Key Mergers And Acquisitions
29.Conjunctivitis Treatment Future Outlook and Potential Analysis
TOP MAJOR PLAYERS:
- Pfizer Inc.
- Johnson and Johnson
- AbbVie Inc.
- Novartis AG
- Sanofi SA
- Boehringer Ingelheim
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
